Warren Buffett's Last Hunt for a Massive Deal as Berkshire CEO

Warren Buffett's final months as Berkshire Hathaway's CEO were marked by a continued search for a significant acquisition, often referred to as an 'elephant.' Despite holding a record $381.6 billion in cash reserves, Buffett struggled to identify suitable opportunities at prices he deemed reasonable.

Buffett emphasized that the issue wasn't a lack of capital but rather the absence of appropriately valued targets. He expressed a readiness to deploy $100 billion on a compelling deal, underscoring the challenge of finding acquisitions that could significantly impact Berkshire's overall performance.

In October 2025, Berkshire finalized a $9.7 billion cash deal to acquire Occidental Petroleum's chemical business, OxyChem, marking its largest purchase since the $11.6 billion acquisition of insurer Alleghany in 2022.

Berkshire's substantial cash reserves accumulated following strategic reductions in its holdings of Apple and Bank of America. Buffett has frequently cautioned against holding excessive cash, viewing it as a poor long-term asset, even while maintaining ample reserves to navigate unforeseen economic challenges.

With Greg Abel now at the helm, Berkshire shareholders may expect quicker deployment of the company's substantial cash reserves, adding pressure on the new CEO to identify and execute value-accretive acquisitions.

Buffett wanted to deploy Berkshire's massive cash reserves into valuable businesses.

Finding large-scale opportunities at prices he considered sensible.

Do you think Berkshire Hathaway will make a significant acquisition soon under Greg Abel's leadership? Share this article with others who need to stay ahead of this trend!